Active Ingredient: ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
Proprietary Name: STEGLUJAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;EQ 100MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209805
Product Number: 002
Approval Date: Dec 19, 2017
Applicant Holder Full Name: MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC
Marketing Status:
Prescription
Patent and Exclusivity Information